Keyword: Flucelvax

With no FluMist, CDC worries flu vaccination rates could slip

About 20 million people and one-third of children in the U.S. received AstraZeneca’s FluMist last year to protect against the seasonal virus, health officials told reporters during a press conference. And with the nasal mist no longer an option this year, the CDC is concerned that vaccination rates could suffer.